Predictors of outcomes in patients on peritoneal dialysis: A 2-year nationwide cohort study
暂无分享,去创建一个
S. Nakai | K. Nitta | N. Hanafusa | T. Hamano | M. Abe | H. Nakamoto | J. Hoshino | Atsushi Wada | I. Masakane
[1] T. Hasegawa,et al. Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] S. Nakai,et al. FP655EFFECTS OF DIALYZER MEMBRANE MATERIALS ON SURVIVAL IN CHRONIC HEMODIALYSIS PATIENTS: A 2-YEAR COHORT STUDY FROM THE ANNUAL SURVEY OF THE JAPANESE RENAL DATA REGISTRY , 2018 .
[3] S. Nakai,et al. Is there a "burnt-out diabetes" phenomenon in patients on hemodialysis? , 2017, Diabetes research and clinical practice.
[4] S. Nakai,et al. High-Performance Membrane Dialyzers and Mortality in Hemodialysis Patients: A 2-Year Cohort Study from the Annual Survey of the Japanese Renal Data Registry , 2017, American Journal of Nephrology.
[5] Chul-woo Yang,et al. The atherogenic index of plasma and the risk of mortality in incident dialysis patients: Results from a nationwide prospective cohort in Korea , 2017, PloS one.
[6] T. Hasegawa,et al. Peritoneal Dialysis Registry With 2013 Survey Report , 2016, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[7] A. Gorke. Dialysis Outcomes and Practice Patterns Study (DOPPS) , 2016, Dialyse aktuell.
[8] K. Yokoyama,et al. Clinical efficacy of combined therapy with peritoneal dialysis and hemodialysis , 2016, Renal Replacement Therapy.
[9] Chul-woo Yang,et al. Glycemic Control Modifies Difference in Mortality Risk Between Hemodialysis and Peritoneal Dialysis in Incident Dialysis Patients With Diabetes , 2016, Medicine.
[10] T. Hasegawa,et al. Peritoneal Dialysis Registry With 2012 Survey Report , 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[11] K. Wakai,et al. An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013) , 2015, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[12] K. Kalantar-Zadeh,et al. Haemodialysis-induced hypoglycaemia and glycaemic disarrays , 2015, Nature Reviews Nephrology.
[13] T. Nakao,et al. Combined Therapy with Peritoneal Dialysis and Hemodialysis: A Multicenter Retrospective Observational Cohort Study in Japan , 2014, Blood Purification.
[14] O. Dekkers,et al. Survival in dialysis patients is not different between patients with diabetes as primary renal disease and patients with diabetes as a co-morbid condition , 2011, BMC nephrology.
[15] M. Ikeda,et al. Clinical impact of a combined therapy of peritoneal dialysis and hemodialysis. , 2010, Clinical nephrology.
[16] B. Piraino,et al. PERITONEAL DIALYSIS-RELATED INFECTIONS RECOMMENDATIONS: 2010 UPDATE , 2010, Peritoneal Dialysis International.
[17] M. Tuncer,et al. Advanced oxidative protein products are independently associated with endothelial function in peritoneal dialysis patients , 2009, Nephrology.
[18] D. Naimark,et al. Patient and technique survival of diabetics on peritoneal dialysis: one-center's experience and review of the literature. , 2008, Clinical nephrology.
[19] K. Kalantar-Zadeh,et al. Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes. , 2007, Journal of the American Society of Nephrology : JASN.
[20] W. Winkelmayer,et al. Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands. , 2007, Kidney international.
[21] David W. Johnson,et al. Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. , 2005, Journal of the American Society of Nephrology : JASN.
[22] B. Lindholm,et al. Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[23] R. Foley,et al. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. , 2004, Kidney international.
[24] K. Fushimi,et al. An Overview of Regular Dialysis Treatment in Japan (as of 31 December 2002) † , 2004, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[25] David W. Johnson,et al. Predictors of baseline peritoneal transport status in Australian and New Zealand peritoneal dialysis patients. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[26] M. Nakayama,et al. Review of Combination of Peritoneal Dialysis and Hemodialysis as a Modality of Treatment for End‐stage Renal Disease , 2004, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[27] R. Wolfe,et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2003, Journal of the American Society of Nephrology : JASN.
[28] R. Fluck,et al. Glycemic control in diabetic CAPD patients assessed by continuous glucose monitoring system (CGMS). , 2003, Kidney international.
[29] S. Davies,et al. Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[30] C. Holmes,et al. Strategies to Reduce Glucose Exposure in Peritoneal Dialysis Patients , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[31] D. Choudhury,et al. Advanced glycation end products: a Nephrologist's perspective. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[32] F. Valderrábano. Renal replacement therapy. What are the differences between Japan and Europe? , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[33] F. Port,et al. Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[34] Y. Maruyama. Does Combined Therapy with Peritoneal Dialysis and Hemodialysis Improve Prognosis? , 2018, Contributions to nephrology.
[35] S. Nakai,et al. An overview of regular dialysis treatment in Japan (As of December 31, 2012) , 2014 .
[36] Ross Ward,et al. United States Renal Data System , 2011 .